Michael A Osborne is Professor of Machine Learning at the University of Oxford and leads the Bayesian Exploration Lab . He serves as Director of the EPSRC Centre for Doctoral Training in Autonomous Intelligent Machines and Systems and co-directs the Oxford Martin AI Governance Initiative. His research focuses on Bayesian optimization, Gaussian processes, and probabilistic numerics with applications in quantum devices, battery modeling, and AI governance. Key Positions: Professor of Machine Learning, University of Oxford Official Fellow, Exeter College Co-founder of Mind Foundry Lead Researcher, Oxford Martin Programme on Technology and Employment Research Themes: Probabilistic modeling for quantum systems Uncertainty quantification in energy storage AI safety and societal impact analysis Automated experimental design Quantum device calibration Probabilistic numerical methods Technical Contributions: Bridging reality gap in quantum devices Efficient Bayesian quadrature techniques Personalized neurostimulation algorithms Automated measurement protocols Quantum-classical hybrid ML
Univ-Prof. Dr. med. Malek Bajbouj serves as Director of the Institute for Affective Neuroscience and Emotion Modulation at Charité – University Medicine Berlin's Campus Benjamin Franklin (CBF), operating within the Department of Neurology, Neurosurgery and Psychiatry (CC 15). His position integrates clinical leadership with translational neuroscience research focused on severe mental illnesses. Dr. Bajbouj's research program centers on affective neuroscience and emotion dysregulation mechanisms in psychiatric disorders, particularly schizophrenia spectrum conditions and depression. He pioneers multimodal intervention approaches combining neuromodulation (tDCS), oxytocin augmentation, mindfulness therapies, and digital health tools. His work emphasizes translational biomarker development using neuroimaging, machine learning, and physiological stress parameter analysis to personalize treatment for treatment-resistant populations. Analysis of his 2023-2025 publications reveals three dominant research trajectories: (1) novel treatment combinations for negative symptoms in schizophrenia (oxytocin + mindfulness, yoga therapy); (2) real-world implementation of neuromodulation (at-home tDCS protocols, technical efficacy monitoring); and (3) global mental health responses to crises (pandemic impacts on vulnerable groups, culturally adapted refugee interventions). His methodology consistently employs rigorous randomized controlled trials with embedded biomarker studies. As director of his eponymous institute, Dr. Bajbouj leads a multidisciplinary team conducting neuroimaging studies, clinical trials, and international collaborations focused on emotion modulation pathways. The institute coordinates research across CC 15's clinical infrastructure at CBF Building V, with particular emphasis on bridging laboratory neuroscience with clinical psychiatry through the DepressionDC and OXYMIND trial frameworks.
Chang S. (CS) Nam is a Professor of Industrial and Systems Engineering at North Carolina State University, with affiliations in the UNC/NCSU Joint Department of Biomedical Engineering and the Department of Psychology. He holds editorial roles as Editor-in-Chief of Brain-Computer Interfaces journal and is a Fellow of the Human Factors and Ergonomics Society. His research focuses on advancing human-centered technologies through neuroergonomics, brain-computer interfaces (BCIs), and rehabilitation engineering, supported by grants from NSF, AFRL, AFOSR, and the Laboratory for Analytic Sciences. Education: Ph.D. in Industrial Engineering, Virginia Tech (2003) MSIE in Industrial Engineering, State University of New York at Buffalo (2000) Research Interests: His work spans neurorehabilitation, haptic interaction design, and BCI applications, aiming to bridge human cognitive and neural processes with technological systems. Key areas include adaptive human-computer interaction, EEG-based emotion recognition, and spatial augmented reality for skill training. Grants & Awards: Recipient of NSF CAREER Award (2010), Air Force Summer Faculty Fellowship (2018), and the Leland S. Kollmorgen Spirit of Innovation Award (2019) Editor of Brain-Computer Interfaces Handbook: Technological and Theoretical Advances (CRC Press) Advising & Labs: Advises students like Lingchao Mao and Priscille Koutouan Leads the Brain-Computer Interface and Neuroergonomics Lab, developing BCI systems for communication in vegetative states and neurorehabilitation
Dr. Camilla Nord serves as Assistant Professor of Cognitive Neuroscience at the University of Cambridge's Department of Psychiatry and is Programme Leader at the MRC Cognition and Brain Sciences Unit. She holds dual appointments as Co-Director of Postgraduate Education & Director of the MPhil in Cognitive Neuroscience at the MRC CBU, and as Fellow and Director of Studies at Christ's College Cambridge. Nord directs the Mental Health Neuroscience Lab (nordlab.co.uk), which focuses on translating neuroscience into improved mental health treatments through innovative pharmacological, psychological, and neurostimulation interventions. Her research spans three interconnected streams: Discovery Science investigates brain-body interactions including interoception, circadian rhythms, and metabolism as neglected sources of mental health information; Experimental Medicine employs pharmacological manipulation, brain stimulation, and psychological interventions to establish causal relationships between physiological mechanisms and mental health conditions; and Translational Neuroscience develops clinical trials for neuroscience-based interventions, particularly 'acute augmentations' that enhance psychological therapy efficacy. Her lab has demonstrated how gut states cause disgust avoidance and how psychological therapy techniques alter negative learning processes. Analysis of Nord's publication record reveals a strong emphasis on computational approaches to mental health, with particular focus on depression treatment mechanisms. Her work increasingly integrates brain-body interactions, especially gut-brain and metabolic pathways, into mental health frameworks. Recent publications show growing emphasis on patient-centered research, interoception, and transdiagnostic approaches that cut across traditional psychiatric categories. Wellcome Career Development Award (£1.5 million) Wellcome Mental Health Award (£4.3 million, jointly awarded with Prof. Sarah Garfinkel) Sunday Times Book of the Year (2023) for 'The Balanced Brain: The Science of Mental Health' Financial Times Book of the Year (2023) for 'The Balanced Brain: The Science of Mental Health' Nord actively mentors PhD students and postdoctoral researchers, with her trainees receiving prestigious awards including the British Association of Psychopharmacology (BAP) Poster Prize, BAP Hannah Steinberg Bursary, and Alwyn Lishman Prize. Her lab is currently funded by MRC intramural funding, a Wellcome Career Development Award, and a Wellcome Mental Health Award, supporting innovative research at the intersection of neuroscience and mental health treatment. The Mental Health Neuroscience Lab operates within the MRC Cognition and Brain Sciences Unit, collaborating extensively with researchers across Cambridge and internationally. The lab maintains strong connections with clinical services and patient groups, ensuring research remains grounded in real-world mental health challenges. Current work focuses on transcranial ultrasound stimulation, gut-brain axis interventions, and computational modeling of mental health mechanisms.
Ian Greenhouse serves as an Assistant Professor in the Department of Human Physiology within the College of Arts and Sciences at the University of Oregon. He directs the Action Control Laboratory, where he investigates the neurophysiological mechanisms underlying human movement initiation and cancellation using multimodal approaches including electrophysiology, neuroimaging, and brain stimulation. Education: Undergraduate degree in Psychology from Tufts University Ph.D. from the University of California, San Diego Postdoctoral training at the University of California, Berkeley Research Focus: Dr. Greenhouse's work centers on action control neurophysiology , specifically examining motor inhibition processes during response stopping and preparation. His lab employs electromyography (EMG) , transcranial magnetic stimulation (TMS) , and magnetic resonance spectroscopy (MRS) to probe corticospinal excitability in healthy and clinical populations. Key investigations include neural computations for action preparation, biomarkers of stopping failure, and relationships between motor performance and brain chemistry (e.g., GABA). Publication Trends: Analysis of Dr. Greenhouse's 2022-2025 publications reveals intensified focus on subcomponents of response inhibition (pause vs. cancel processes) and neurochemical modulation of motor control. His work increasingly integrates menstrual cycle effects on GABA with action stopping metrics, while maintaining core investigations of corticospinal dynamics during unimanual/bimanual preparation. Recent studies show growing clinical applications in stroke rehabilitation. Scientific Awards: No awards were documented in the source materials. Advising and Research: As laboratory director, Dr. Greenhouse mentors students in the Action Control Laboratory's research program. Although specific grants aren't detailed, his high-output publication record spanning neuroimaging, electrophysiology, and clinical applications suggests sustained external funding for equipment-intensive neuroscience research. Laboratory Operations: The Action Control Laboratory (https://actioncontrollab.uoregon.edu) operates from Gerlinger Hall (Room 348), utilizing TMS-EMG integration, MRS, and behavioral paradigms to study action control. Current projects examine preparatory inhibition in stroke recovery, interhemispheric dynamics during movement preparation, and individual differences in stopping processes using the stop-signal task framework.
Kris Baetens is a Professor in the Department of Psychology Brain, Body and Cognition at Vrije Universiteit Brussel (VUB). His research focuses on the neural mechanisms underlying social cognition, mentalization, and inhibitory control, particularly exploring the role of the cerebellum and prefrontal cortex in these processes. He employs techniques such as transcranial direct current stimulation (tDCS), EEG, and fMRI to investigate cognitive and clinical phenomena. Leading projects like ANI423 (neural correlates of inhibitory control in adolescents) and FWOAL1160 (cerebellum's role in social cognition). Recipient of the EUTOPIA Young Leaders Academy fellowship (2024-2026). Active collaborations in the PRISM network for mental health research. Key research interests include: - Cerebellar contributions to cognitive and social functions - Neurostimulation techniques for mental health interventions - Mentalizing processes in social action prediction - Personality and learning mechanisms His articles consistently analyze the interplay between neural structures like the cerebellum and behavioral outcomes in clinical and cognitive contexts. Recent work emphasizes applications of tDCS in treating alcohol use disorders and disordered eating, highlighting translational research in non-invasive brain stimulation. Advising/Grants: Supervises student research projects and manages grants from FWO and OZR agencies. Labs/Teams: Core member of the PRISM network and involved in the EUTOPIA fellowship initiative.
Susanne M. Jaeggi is a Professor of Psychology at Northeastern University, with additional affiliations in the Bouve College of Health Sciences and the College of Arts, Media, and Design. Her research focuses on cognitive training, executive functions, and individual differences in cognition across the lifespan. She holds PhDs in Cognitive Psychology and Neuroscience from the University of Bern (Switzerland), and completed postdoctoral work in Cognitive Neuroscience at the University of Michigan. Her work has been funded by NIH, NSF, IES, ONR, and the Advanced Education Research and Development Fund (AERDF). She leads the Working Memory & Plasticity Lab , which develops interventions to improve working memory and executive functions, and co-leads the Brain Game Center for Mental Fitness and Well-Being , creating evidence-based brain fitness tools. Jaeggi’s research emphasizes understanding mechanisms of cognitive improvement through training, including neuroplasticity and individual variability. Key areas include cognitive aging interventions, gamification, sensory-cognitive interactions, and the impact of socioeconomic factors on academic achievement. Her work integrates behavioral experiments, neuroimaging, and digital health technologies to address real-world challenges in education and healthcare. Recent studies explore music/art-based interventions, brain stimulation (e.g., tDCS), and scalable cognitive assessments. Collaborations span disciplines, with publications addressing topics like neural correlates of training, motivational features in interventions, and cross-modal perception. Her labs emphasize translating findings into public-facing tools, such as freely accessible brain fitness apps. Current projects include optimizing interventions for ADHD populations and leveraging digital platforms for global mental fitness.
Dr. Daniel Keeser is a Research Fellow and Research Group Leader at the Department of Psychiatry and Psychotherapy of the University of Munich (LMU) and affiliated with the NeuroImaging Core Unit Munich (NICUM). His work focuses on clinical deep phenotyping and multimodal neuroimaging, integrating advanced MRI, EEG, and non-invasive brain stimulation methods to study severe mental and neurological disorders. Research Interests: Elucidating neurobiological mechanisms of schizophrenia, major depressive disorder, and Alzheimer's disease through multimodal neuroimaging and neuromodulation. His recent publications highlight methodologies like resting-state fMRI, diffusion tensor imaging, and transcranial magnetic stimulation combined with MRI, emphasizing personalized treatment strategies. Collaborative affiliations include the University Hospital of LMU Munich and the Clinical Deep Phenotyping (CDP) Working Group. Affiliations: NeuroImaging Core Unit Munich (NICUM) Department of Psychiatry and Psychotherapy, University of Munich (LMU)
Jeffrey J. Borckardt is a Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC). His primary research focuses on neuromodulation techniques, including transcranial direct current stimulation (tDCS), transcutaneous auricular vagus nerve stimulation (taVNS), and transcranial focused ultrasound (tFUS), applied to chronic pain management and opioid use reduction. He leads multidisciplinary clinical trials investigating the efficacy of these technologies in diverse populations, including veterans and patients with hypermobile Ehlers-Danlos syndrome. Key research areas include the neurobiological mechanisms of pain, the integration of psychological interventions like cognitive-behavioral therapy (CBT), and the development of telehealth-delivered therapies. His work emphasizes improving healthcare access disparities and optimizing interprofessional teamwork. He collaborates across institutions, including the VA and international ENIGMA initiatives, to advance translational neuroscience. Recent studies explore the synergistic effects of tAN and tDCS with behavioral interventions, pain biomarkers in spine treatments, and real-time fMRI neurofeedback for addiction. His clinical trials often involve double-blind, sham-controlled designs to rigorously evaluate neuromodulation efficacy. Institutional Affiliations: MUSC College of Medicine, VA Medical Center Research Themes: Neuromodulation, Pain Rehabilitation, Opioid Crisis Mitigation
Professor Davinia Fernandez-Espejo holds the Chair of Neuropsychology and Clinical Neuroscience at the University of Birmingham's School of Psychology through The Centre for Human Brain Health (CHBH). Previously, she served as a Professor at Western University from 2015-2018.
David A. Gallo is a Professor at the University of Chicago, affiliated with the Department of Psychology. He joined the faculty in 2005 after completing a B.A. at Wesleyan University (1997), a Ph.D. at Washington University in St. Louis (2002), and an NIH-sponsored postdoctoral fellowship at Harvard University. His research focuses on neurocognitive processes of human memory, particularly memory accuracy, distortion, aging effects, and Alzheimer’s disease. He explores how memory is actively reconstructed and influenced by contextual and pharmacological factors. Key research interests include metacognitive and nonconscious processes, cognitive neuroscience, and evolutionary psychology. He investigates how stereotypes, psychoactive drugs, and contextual cues affect memory accuracy and monitoring. His lab, the Memory Research Lab, employs neuroimaging, behavioral experiments, and pharmacological interventions to study these phenomena. His recent articles highlight studies on transcranial direct current stimulation (tDCS), contextual reinstatement effects, and drug-induced memory modulation. He emphasizes the role of distinctiveness in reducing memory errors and examines the neural mechanisms underlying retrieval monitoring. His work spans developmental, clinical, and applied domains, with implications for aging populations and cognitive health. Gallo teaches courses such as Cognitive Neuroscience of Aging and Evolutionary Psychology, integrating empirical research with theoretical frameworks. His contributions bridge basic science and clinical applications, addressing challenges in memory disorders and cognitive enhancement strategies.
Heidi Johansen-Berg is Pro-Vice Chancellor (Strategic Initiatives) at the University of Oxford and Associate Head (Research and Innovation) in the Medical Sciences Division. She holds a Professorship in Cognitive Neuroscience and a Wellcome Principal Research Fellowship at the Nuffield Department of Clinical Neurosciences, where she leads the Plasticity Group at the Oxford Centre for Functional MRI of the Brain (FMRIB). Her research centers on neuroplasticity mechanisms in the sensorimotor system, with emphasis on white matter plasticity, activity-dependent myelination, and implications for stroke rehabilitation and age-related brain decline. She integrates multimodal neuroimaging with behavioral studies to investigate how the brain adapts to learning, experience, and damage, translating findings into therapeutic interventions for neurological conditions. Recent publications reveal strong thematic trends in sleep-motor interactions post-stroke, exercise-induced neuroprotection in aging and adolescence, and experience-dependent white matter remodeling. Her work demonstrates how physical activity modulates brain structure-function relationships across the lifespan, with direct applications for neurorehabilitation protocols. Scientific recognition includes: Fellow of the Royal Society (FRS) Fellow of the Academy of Medical Sciences (FMedSci) Wellcome Principal Research Fellowship Professor Johansen-Berg directs the WIN Plasticity Group and co-leads the WIN Neuroplastics Network and Oxford University Centre for Integrative Neuroimaging (OxCIN). Her research program drives translational initiatives in stroke recovery and brain health maintenance, with ongoing projects examining digital sleep therapies, myelin dynamics, and exercise neuroscience through large-scale clinical trials and advanced imaging methodologies.
Dawson Kidgell is an Associate Professor in the Department of Physiotherapy at Monash University, Faculty of Medicine. He is an active researcher and PhD supervisor with a strong focus on the neurophysiology of exercise, particularly neuroplasticity and motor cortex responses to strength training and non-invasive brain stimulation techniques such as Transcranial Magnetic Stimulation (TMS) and transcranial direct current stimulation (tDCS). His research interests include understanding how the nervous system adapts to exercise, rehabilitation, and neuromodulation. He employs advanced electrophysiological methods—TMS, tDCS, EMG, and spinal reflex testing—to explore corticospinal excitability, intracortical inhibition, and motor learning. His work has significant implications for sports science, rehabilitation of neuromuscular injuries, and aging populations. Recent publications (2020–2024) highlight a strong trend in systematic reviews and meta-analyses on tDCS, corticospinal responses to training, and clinical applications in tendinopathy, concussion, and aging. His research frequently investigates bilateral transfer, cross-education of strength, and the neural mechanisms underlying rehabilitation interventions. Scientific Awards: University of Jyväskylä Visiting Fellow grant (2023) Research Funding and Supervision: Associate Professor Kidgell has secured over $2.5 million in research funding. He has successfully supervised 11 PhD students to completion and currently mentors 5 additional PhD candidates. His research projects include NHMRC-funded studies on neurophysiological markers of balance and equipment grants for advanced neurostimulation tools. Laboratories and Research Teams: His work is conducted within neurophysiology and exercise neuroscience labs at Monash, often in collaboration with interdisciplinary teams focusing on motor control, rehabilitation, and sports medicine.
Professor Barbara Singer is a Professor of Neurological Rehabilitation at Edith Cowan University’s School of Medical and Health Sciences. With over 30 years of clinical and academic experience, she previously led a postgraduate program in neurological rehabilitation at the University of Western Australia (2004–2016). She currently teaches in the NRB5112 Translational Science course. Her education includes a Doctor of Philosophy from the University of Western Australia (2003) and a Postgraduate Diploma in Health Sciences from Curtin University (1988). As a Neurological Physiotherapist, she is an Honoured member of the Australian Physiotherapy Association and a Fellow of the Australian College of Physiotherapists. Barbara’s research focuses on spasticity management, stroke rehabilitation, functional neurological disorders, and self-management strategies for neurological conditions. Notable contributions include clinical practice guidelines for lateropulsion management and studies on constraint-induced movement therapy implementation. Her awards include the 2010 WA Branch President’s Award (Australian Physiotherapy Association) and the 2023 Honoured Membership (Australian Physiotherapy Association). She has supervised numerous PhD and master’s students, focusing on topics like lateropulsion in stroke recovery and functional neurological disorders.
Professor Colleen Loo, MBBS (Hons), FRANZCP, MD (research doctorate), is a clinical psychiatrist and Professor of Psychiatry at the University of New South Wales and the Black Dog Institute in Sydney, Australia. She is an internationally recognized clinical expert and researcher in electroconvulsive therapy (ECT), Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), and ketamine, having led the first Australian RCTs of these interventions in depression. With over 300 peer-reviewed publications, she has established herself as a leading authority in interventional psychiatry. Professor Loo's research expertise spans multiple domains of neuromodulation and novel psychiatric treatments. Her team at UNSW, based at the Black Dog Institute, focuses on transcranial magnetic stimulation, transcranial direct current stimulation, ECT, ketamine, and psychedelics. Current research streams include clinical trials of novel treatments for depression and anorexia, experiments improving brain stimulation approaches, cognitive neuroscience using brain stimulation to enhance cognition, combining brain stimulation with neuroimaging techniques, real-world treatment data collection through the CARE network, and computational modeling of brain stimulation effects. Her work bridges fundamental neuroscience with practical clinical implementation across diverse patient populations. Analysis of Professor Loo's recent publication record reveals a strong emphasis on advancing clinical applications of neuromodulation techniques, with particular focus on ketamine therapy (especially through the KADS trial), ECT optimization, and expanding applications across different demographic groups including the elderly. Her work spans from fundamental biological mechanisms to economic evaluations and real-world implementation challenges. Grant funding from Australian NHMRC Grant funding from MRFF Grant funding from US-based NARSAD and Stanley Foundations Grant funding from UK NHS/MRC Grant funding from Singapore NMC Grant funding from Ramsay Hospital Research Foundation Professor Loo has established clinics for novel treatments for depression (TMS, ketamine, tDCS) at the Black Dog Institute and Ramsay Clinic Northside, Sydney. She has developed professional training courses for psychiatrists in ECT, TMS, tDCS, and ketamine, and serves as an expert adviser to Australian government health departments and the Royal Australian and New Zealand College of Psychiatrists. She is the first person outside North America to become President of the International Society for ECT and Neurostimulation (ISEN). Professor Loo leads the Neurostimulation & Interventional Psychiatry Team at the Black Dog Institute and co-founded the Clinical Alliance and Research in ECT and Related Treatments (CARE) network, which collects real-world treatment data to improve clinical practice in neurostimulation and interventional psychiatry across multiple international sites.
